These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 10181728)

  • 1. Solicitation of information and recommendations for developing OIG compliance program guidance for the durable medical equipment industry--HHS. Notice.
    Fed Regist; 1998 Aug; 63(152):42409-10. PubMed ID: 10181728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solicitation of information and recommendations for developing OIG compliance program guidance for certain Medicare+Choice organizations--OIG, HHS. Notice.
    Fed Regist; 1998 Sep; 63(183):50577-8. PubMed ID: 10185802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Publication of the OIG compliance program guidance for home health agencies--OIG. Notice.
    Fed Regist; 1998 Aug; 63(152):42410-26. PubMed ID: 10181729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Publication of the OIG compliance program guidance for hospitals--OIG. Notice.
    Fed Regist; 1998 Feb; 63(35):8987-98. PubMed ID: 10177742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Publication of OIG compliance program guidance for clinical laboratories--HHS. Notice.
    Fed Regist; 1998 Aug; 63(163):45076-87. PubMed ID: 10182693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solicitation of information and recommendations for developing OIG compliance program guidance for certain Medicare+Choice organizations--OIG, HHS. Correction.
    Fed Regist; 1998 Oct; 63(190):52799. PubMed ID: 10185821
    [No Abstract]   [Full Text] [Related]  

  • 7. Using the OIG model compliance programs to fight fraud.
    Lovitky JA; Ahern J
    Healthc Financ Manage; 2002 Mar; 56(3):64-8. PubMed ID: 11899726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Third-party biller compliance guidance emphasizes risk awareness.
    Saner RJ
    Healthc Financ Manage; 1999 Mar; 53(3):43-5. PubMed ID: 10351055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DMEPOS (Durable Medical Equipment, Prosthetics, Orthotics and Supply) model compliance program: does the OIG have it right?
    Parver C; O'Connor B
    Caring; 1999 Jun; 18(6):20-3. PubMed ID: 10538888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Publication of the OIG's provider self-disclosure protocol--Office of Inspector General (OIG), HHS. Notice.
    Fed Regist; 1998 Oct; 63(210):58399-403. PubMed ID: 10185849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Publication of OIG Special Fraud Alerts: home health fraud, and fraud and abuse in the provision of medical supplies to nursing facilities--HHS. Notice.
    Fed Regist; 1995 Aug; 60(154):40847-51. PubMed ID: 10144395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Publication of the OIG model compliance plan for clinical laboratories--HHS. Notice.
    Fed Regist; 1997 Mar; 62(41):9435-41. PubMed ID: 10166060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicare, Medicaid, and Children's Health Insurance Programs; additional screening requirements, application fees, temporary enrollment moratoria, payment suspensions and compliance plans for providers and suppliers. Final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS); Office of Inspector General (OIG), HHS
    Fed Regist; 2011 Feb; 76(22):5861-971. PubMed ID: 21287774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effective compliance for the small provider.
    Fedor FP
    Healthc Financ Manage; 2000 Jul; 54(7):56-60. PubMed ID: 11009826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OIG releases compliance guidelines for HME providers.
    Wright K
    Caring; 1999 Mar; 18(3):40. PubMed ID: 10387564
    [No Abstract]   [Full Text] [Related]  

  • 16. The new hospice compliance plan: defining and addressing risk areas.
    Jones DH; Woods K
    Caring; 2000 May; 19(5):30-2, 34-5. PubMed ID: 11009798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solicitation of comments on the OIG/HCFA Special Advisory Bulletin on the patient anti-dumping statute--OIG and HCFA. Notice of proposed special advisory bulletin.
    Fed Regist; 1998 Dec; 63(234):67486-9. PubMed ID: 10187554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solicitation of new safe harbors and special fraud alerts--Office of Inspector General, HHS. Notice of intent to develop regulations.
    Fed Regist; 1997 Dec; 62(237):65049-53. PubMed ID: 10176580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consolidated billing and compliance program--Part 2.
    Stahl DA
    Nurs Manage; 1998 Jun; 29(6):12-5. PubMed ID: 9807420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.